UNSPSC 51131641: Nadroparin

This classification denotes a low molecular weight heparin with the molecular formula (C14H18NO11)N.2(C12H16NO13S)N.3HO3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1K5KDI46KZ. European Medicines Agency schedules nadroparin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03371MIG. As of Q4 2014, NADROPARIN remains the US FDA Preferred Term for this commodity. SMILES: C(C1C(C(C(C(O1)O)NS(=O)(=O)[O-])O)OC2C(C(C(C(O2)C(=O)[O-])O)O)OS(=O)(=O)[O-])OS(=O)(=O)[O-].

UNSPSC 51131641 Nadroparin is a Commodity code for a specific anticoagulant pharmaceutical product, but recent state and local procurement activity under this code does not align with its nominal scope. The sole recent opportunity posted under 51131641 is Sourcewell's RFP #061626 for law enforcement equipment, which falls outside the pharmaceutical category entirely and represents a tagging mismatch rather than genuine demand for nadroparin in the state and local market.

The source contains no evidence of state and local governments actively procuring nadroparin or related anticoagulants under this code. The Sourcewell RFP, while issued on behalf of multiple Washington state counties (Franklin, Grant, Grays Harbor, Chelan, Yakima) and other jurisdictions nationwide, is structured as a cooperative purchasing vehicle for law enforcement equipment availability to thousands of public entities, not for pharmaceutical procurement. Absent additional recent opportunities correctly tagged under 51131641, the code shows little relevant activity for business development professionals in the pharmaceutical or anticoagulant supply space at the state and local level.